Nicola Riccetti1,2, Isabelle Hempler3, Kerstin Hermes-Moll3, Vitali Heidt3, Thomas Walawgo3, Susanne Singer4,5. 1. Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre, Obere Zahlbacher Str. 69, 55131, Mainz, Germany. nicolariccetti@gmail.com. 2. University Cancer Centre Mainz, Mainz, Germany. nicolariccetti@gmail.com. 3. Scientific Institute of Office-Based Haematologists and Oncologists (WINHO GmbH), Cologne, Germany. 4. Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre, Obere Zahlbacher Str. 69, 55131, Mainz, Germany. 5. University Cancer Centre Mainz, Mainz, Germany.
Abstract
PURPOSE: We compared the perception of office-based haematologists and oncologists regarding the availability of outpatient psycho-social support services (PSSS) for patients with cancer and a migration background, as well as their different experiences with these services. METHODS: Data were collected via an online survey addressing the doctors' socio-demographic characteristics and their perception of-and experience with PSSS. The association between socio-demographic characteristics of the doctors and their experiences with PSSS was tested using Pearson's chi-squared test and Kruskal-Wallis test. RESULTS: A total of 55 doctors were included in this study. More than three doctors in four reported non-sufficient presence of PSSS in foreign languages in their region; one in two reported that the services for patients with migration background should be improved. Most doctors reported missing PSSS in Turkish and Arabic in their region. Doctors with less experience referred patients more often to PSSS hosted in patients' associations (75% vs 25%; p = 0.02), than doctors with more experience. Doctors working in larger cities referred patients less often to PSSS in cancer counselling centres (12% vs 88%; p = 0.01), than doctors working in small or middle-large cities. Male doctors were more satisfied with the network of PSSS' providers, than female doctors (mean score = 2.8 vs 2.2; p = 0.05). CONCLUSIONS: Our results suggest that efforts should be made for a higher regional availability of overall and specific PSSS for non-German speaking patients (especially for Turkish- and Arabic-speaking patients). The experience with PSSS was associated with the doctors' work experience and gender, as well as the location of the practice.
PURPOSE: We compared the perception of office-based haematologists and oncologists regarding the availability of outpatient psycho-social support services (PSSS) for patients with cancer and a migration background, as well as their different experiences with these services. METHODS: Data were collected via an online survey addressing the doctors' socio-demographic characteristics and their perception of-and experience with PSSS. The association between socio-demographic characteristics of the doctors and their experiences with PSSS was tested using Pearson's chi-squared test and Kruskal-Wallis test. RESULTS: A total of 55 doctors were included in this study. More than three doctors in four reported non-sufficient presence of PSSS in foreign languages in their region; one in two reported that the services for patients with migration background should be improved. Most doctors reported missing PSSS in Turkish and Arabic in their region. Doctors with less experience referred patients more often to PSSS hosted in patients' associations (75% vs 25%; p = 0.02), than doctors with more experience. Doctors working in larger cities referred patients less often to PSSS in cancer counselling centres (12% vs 88%; p = 0.01), than doctors working in small or middle-large cities. Male doctors were more satisfied with the network of PSSS' providers, than female doctors (mean score = 2.8 vs 2.2; p = 0.05). CONCLUSIONS: Our results suggest that efforts should be made for a higher regional availability of overall and specific PSSS for non-German speaking patients (especially for Turkish- and Arabic-speaking patients). The experience with PSSS was associated with the doctors' work experience and gender, as well as the location of the practice.
Authors: L M Buffart; M A C Schreurs; H J G Abrahams; J Kalter; N K Aaronson; P B Jacobsen; R U Newton; K S Courneya; J Armes; C Arving; A M Braamse; Y Brandberg; J Dekker; R J Ferguson; M F Gielissen; B Glimelius; M M Goedendorp; K D Graves; S P Heiney; R Horne; M S Hunter; B Johansson; L L Northouse; H S Oldenburg; J B Prins; J Savard; M van Beurden; S W van den Berg; J Brug; H Knoop; I M Verdonck-de Leeuw Journal: Clin Psychol Rev Date: 2020-06-25
Authors: P J Goodwin; M Leszcz; M Ennis; J Koopmans; L Vincent; H Guther; E Drysdale; M Hundleby; H M Chochinov; M Navarro; M Speca; J Hunter Journal: N Engl J Med Date: 2001-12-13 Impact factor: 91.245
Authors: Antje Frey Nascimento; Theresa Tondorf; Sacha I Rothschild; Michael T Koller; Christoph Rochlitz; Alexander Kiss; Rainer M Schaefert; Gunther P Meinlschmidt; Sabina Hunziker; Jens Gaab; Diana Zwahlen Journal: Psychooncology Date: 2018-12-12 Impact factor: 3.894
Authors: N Riccetti; R Felberbaum; F Flock; T Kühn; E Leinert; L Schwentner; S Singer; K Taylor; A Wöckel; W Janni Journal: Support Care Cancer Date: 2022-05-04 Impact factor: 3.359
Authors: J Kalter; I M Verdonck-de Leeuw; M G Sweegers; N K Aaronson; P B Jacobsen; R U Newton; K S Courneya; J F Aitken; J Armes; C Arving; L J Boersma; A M J Braamse; Y Brandberg; S K Chambers; J Dekker; K Ell; R J Ferguson; M F M Gielissen; B Glimelius; M M Goedendorp; K D Graves; S P Heiney; R Horne; M S Hunter; B Johansson; M L Kimman; H Knoop; K Meneses; L L Northouse; H S Oldenburg; J B Prins; J Savard; M van Beurden; S W van den Berg; J Brug; L M Buffart Journal: Psychooncology Date: 2018-03-15 Impact factor: 3.894
Authors: S Singer; S Kuhnt; H Götze; J Hauss; A Hinz; A Liebmann; O Krauss; A Lehmann; R Schwarz Journal: Br J Cancer Date: 2009-02-24 Impact factor: 7.640
Authors: A M H Krebber; L M Buffart; G Kleijn; I C Riepma; R de Bree; C R Leemans; A Becker; J Brug; A van Straten; P Cuijpers; I M Verdonck-de Leeuw Journal: Psychooncology Date: 2013-09-16 Impact factor: 3.894